Medicare Enrolled

Dr. Thomas Johnson, M.D.

Allergy & Immunology · Gainesville, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
4343 W NEWBERRY RD, Gainesville, FL 32607
3523313502
In practice since 2006 (19 years)
NPI: 1255399226 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Johnson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Johnson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Johnson

Dr. Thomas Johnson is an allergy & immunology in Gainesville, FL, with 19 years in practice. Based on federal Medicare data, Dr. Johnson performed 46,587 Medicare services across 3,689 unique beneficiaries.

Between the years covered by Open Payments, Dr. Johnson received a total of $351,992 from 34 pharmaceutical and/or device companies across 850 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Johnson is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 4% volume in FL$ $351,992 industry payments

Medicare Practice Summary

Medicare Utilization ↗
46,587
Medicare services
Top 4% in FL for allergy & immunology
3,689
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,452 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Allergy skin test22,411$3$10
Omalizumab injection (Xolair) for asthma/allergy10,398$30$56
Test for allergy using skin patch4,013$4$11
Allergy injection therapy, multiple injections2,370$8$30
Allergy immunotherapy preparation2,280$11$22
Professional service for single injection of allergen1,250$7$22
Drug injection, under skin or into muscle642$11$68
Office visit, established patient (30-39 min)513$92$134
New patient office visit (45-59 min)391$125$224
Administration and interpretation of patient-focused health risk assessment358$2$8
Test to measure expiratory airflow and volume347$20$70
Office visit, established patient (20-29 min)332$64$120
New patient office visit (30-44 min)319$85$184
Test for allergy using combination of methods with drug or biological239$15$57
Test to determine lung volumes using sensors176$40$155
Test for allergy using allergenic extract injected into skin154$6$12
Test to examine how well the lungs exchange gases131$43$155
Test to measure the level of nitric oxide gas80$14$32
Office visit, established patient (10-19 min)78$42$62
Evaluation of use of breathing device63$13$37
Test to measure expiratory airflow and volume changes before and after medication administration42$29$126
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$351,992
Total received (2018-2024)
Avg $50,285/year across 7 years
Top 3% in FL for allergy & immunology
34
Companies
850
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$340,478 (96.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,996 (2.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,518 (0.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$111,460
2023
$137,636
2022
$47,615
2021
$23,882
2020
$12,713
2019
$15,537
2018
$3,149

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$157,311
AstraZeneca Pharmaceuticals LP
$133,376
OptiNose US, Inc.
$29,972
Optinose US, Inc.
$20,933
Amgen Inc.
$2,959
GENZYME CORPORATION
$1,343
Takeda Pharmaceuticals U.S.A., Inc.
$1,141
Regeneron Healthcare Solutions, Inc.
$873
Novartis Pharmaceuticals Corporation
$616
BioCryst US Sales Co., LLC
$394
Covis Pharma GmBH
$373
Grifols USA, LLC
$361
Genentech USA, Inc.
$297
CSL Behring
$228
ABBVIE INC.
$192
Pharming Healthcare, Inc.
$180
Boehringer Ingelheim Pharmaceuticals, Inc.
$169
PFIZER INC.
$169
Octapharma USA, Inc.
$168
kaleo, Inc.
$136
SANOFI-AVENTIS U.S. LLC
$99
Covis Pharma GmbH
$93
AIMMUNE THERAPEUTICS, INC.
$88
Kaleo, Inc.
$77
ALK-Abello, Inc
$66
Mylan Specialty L.P.
$59
LEO Pharma Inc.
$54
Covis Pharma B.V.
$53
Blueprint Medicines Corporation
$53
Teva Pharmaceuticals USA, Inc.
$51
Aimmune Therapeutics, Inc.
$38
Greer Laboratories, Inc.
$32
Eyevance Pharmaceuticals LLC
$22
Merck Sharp & Dohme Corporation
$18
Top 3 companies account for 91.1% of total payments
Associated products mentioned in payments ›
ADBRY · AIRSUPRA · ALVESCO · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · Auvi-Q · BEVESPI AEROSPHERE · BREO · BREZTRI · CIBINQO · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EOHILIA · EUCRISA · FASENRA · FEVIPIPRANT · FRUZAQLA · Flarex · GLASSIA · Grastek · Haegarda · Hizentra · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORALAIR · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · Prolastin-C Liquid · QVAR · RINVOQ · RUCONEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · XOLAIR · Xembify · Xhance · Xolair · YUPELRI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (97%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for allergy & immunology in FL.

Equivalent to $756 per 100 Medicare services performed
Looking for a allergy & immunology in Gainesville?
Compare allergy & immunologys in the Gainesville area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologys nearby

Geographic Context

Allergy & Immunologys within 10 mi
6
Per 100K population
2.1
County median income
$59,659
Nearest hospital
HCA FLORIDA NORTH FLORIDA HOSPITAL
3.5 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Johnson is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Johnson experienced with allergy skin test?
Based on Medicare claims data, Dr. Johnson performed 22,411 allergy skin test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Johnson receive payments from pharmaceutical companies?
Yes. Dr. Johnson received a total of $351,992 from 34 companies across 850 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Johnson's costs compare to other allergy & immunologys in Gainesville?
Dr. Johnson's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Johnson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →